The tunicamycin derivative TunR2 exhibits potent antibiotic properties with low toxicity in an in vivo Mycobacterium marinum-zebrafish TB infection model.
Journal
The Journal of antibiotics
ISSN: 1881-1469
Titre abrégé: J Antibiot (Tokyo)
Pays: England
ID NLM: 0151115
Informations de publication
Date de publication:
18 Jan 2024
18 Jan 2024
Historique:
received:
11
08
2023
accepted:
24
11
2023
revised:
20
11
2023
medline:
19
1
2024
pubmed:
19
1
2024
entrez:
18
1
2024
Statut:
aheadofprint
Résumé
Tunicamycins (TUN) are well-defined, Streptomyces-derived natural products that inhibit protein N-glycosylation in eukaryotes, and by a conserved mechanism also block bacterial cell wall biosynthesis. TUN inhibits the polyprenylphosphate-N-acetyl-hexosamine-1-phospho-transferases (PNPT), an essential family of enzymes found in both bacteria and eukaryotes. We have previously published the development of chemically modified TUN, called TunR1 and TunR2, that have considerably reduced activity on eukaryotes but that retain the potent antibacterial properties. A mechanism for this reduced toxicity has also been reported. TunR1 and TunR2 have been tested against mammalian cell lines in culture and against live insect cells but, until now, no in vivo evaluation has been undertaken for vertebrates. In the current work, TUN, TunR1, and TunR2 are investigated for their relative toxicity and antimycobacterial activity in zebrafish using a well-established Mycobacterium marinum (M. marinum) infection system, a model for studying human Mycobacterium tuberculosis infections. We also report the relative ability to activate the unfolded protein response (UPR), the known mechanism for the eukaryotic toxicity observed with TUN treatment. Importantly, TunR1 and TunR2 retained their antimicrobial properties, as evidenced by a reduction in M. marinum bacterial burden, compared to DMSO-treated zebrafish. In summary, findings from this study highlight the characteristics of recently developed TUN derivatives, mainly TunR2, and its potential for use as a novel anti-bacterial agent for veterinary and potential medical purposes.
Identifiants
pubmed: 38238588
doi: 10.1038/s41429-023-00694-z
pii: 10.1038/s41429-023-00694-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to the Japan Antibiotics Research Association.
Références
CDC. Centers for Disease Control and Prevention. 2022 [cited 2022 Sep 5]. The biggest antibiotic-resistant threats in the U.S. Available from: https://www.cdc.gov/drugresistance/biggest-threats.html
Sekhri L, Kadri ML, Samira C, Senigra M. Synthesis of penicillin derivatives and study of their biological antibacterial activities. Biomed Pharm J. 2015;1:257–64.
Pan X, He Y, Chen T, Chan KF, Zhao Y. Modified Penicillin Molecule with Carbapenem-Like Stereochemistry Specifically Inhibits Class C β-Lactamases. Antimicrob Agents Chemother. 2017;61:e01288–17.
pubmed: 28971874
pmcid: 5700298
doi: 10.1128/AAC.01288-17
Zhu X, Liu D, Singh AK, Drolia R, Bai X, Tenguria S, et al. Tunicamycin Mediated Inhibition of Wall Teichoic Acid Affects Staphylococcus aureus and Listeria monocytogenes Cell Morphology, Biofilm Formation and Virulence. Front Microbiol. 2018;9:1352.
pubmed: 30034372
pmcid: 6043806
doi: 10.3389/fmicb.2018.01352
Huszár S, Singh V, Polčicová A, Baráth P, Barrio MB, Lagrange S, et al. N-Acetylglucosamine-1-Phosphate Transferase, WecA, as a Validated Drug Target in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2017;61:e01310–17.
pubmed: 28874370
pmcid: 5655080
doi: 10.1128/AAC.01310-17
Cundell DR, Tuomanen EI. Receptor specificity of adherence of Streptococcus pneumoniae to human type-II pneumocytes and vascular endothelial cells in vitro. Micro Pathog. 1994;17:361–74.
doi: 10.1006/mpat.1994.1082
Cantagrel V, Lefeber DJ. From glycosylation disorders to dolichol biosynthesis defects: a new class of metabolic diseases. J Inherit Metab Dis. 2011;34:859–67.
pubmed: 21384228
pmcid: 3137772
doi: 10.1007/s10545-011-9301-0
Eichler J, Imperiali B. Biogenesis of Asparagine-Linked Glycoproteins Across Domains of Life—Similarities and Differences. ACS Chem Biol. 2018;13:833–7. https://pubs.acs.org/doi/pdf/10.1021/acschembio.8b00163
pubmed: 29481041
pmcid: 6338551
doi: 10.1021/acschembio.8b00163
Lehle L, Strahl S, Tanner W. Protein Glycosylation, Conserved from Yeast to Man: A Model Organism Helps Elucidate Congenital Human Diseases. Angew Chem Int Ed. 2006;45:6802–18.
doi: 10.1002/anie.200601645
Bugg TDH, Kerr RV. Mechanism of action of nucleoside antibacterial natural product antibiotics. J Antibiot (Tokyo). 2019;72:865–76.
pubmed: 31471595
doi: 10.1038/s41429-019-0227-3
Shan L, Wenling Q, Mauro P, Stefano B. Antibacterial Agents Targeting the Bacterial Cell Wall. Curr Med Chem. 2020;27:2902–26.
pubmed: 32003656
doi: 10.2174/0929867327666200128103653
Schröder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res Mol Mech Mutagen. 2005;569:29–63.
doi: 10.1016/j.mrfmmm.2004.06.056
Abdullahi A, Stanojcic M, Parousis A, Patsouris D, Jeschke MG. Modeling Acute ER stress in vivo and in vitro. Shock Augusta Ga. 2017;47:506–13.
pubmed: 27755507
doi: 10.1097/SHK.0000000000000759
Tkacz JS, Lampen O. Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf-liver microsomes. Biochem Biophys Res Commun. 1975;65:248–57.
pubmed: 167767
doi: 10.1016/S0006-291X(75)80086-6
Price NPJ, Jackson MA, Singh V, Hartman TM, Blackburn JA, Dowd PF. Synergistic enhancement of beta-lactam antibiotics by modified tunicamycin analogs TunR1 and TunR2. J Antibiot (Tokyo). 2019;72:807–15.
pubmed: 31420587
doi: 10.1038/s41429-019-0220-x
Price NP, Hartman TM, Li J, Velpula KK, Naumann TA, Guda MR, et al. Modified tunicamycins with reduced eukaryotic toxicity that enhance the antibacterial activity of β-lactams. J Antibiot (Tokyo). 2017;70:1070–7.
pubmed: 28951601
doi: 10.1038/ja.2017.101
Dong YY, Wang H, Pike ACW, Cochrane SA, Hamedzadeh S, Wyszyński FJ, et al. Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design. Cell. 2018;175:1045–e16.
pubmed: 30388443
pmcid: 6218659
doi: 10.1016/j.cell.2018.10.037
Mitachi K, Mingle D, Effah W, Sánchez-Ruiz A, Hevener KE, Narayanan R, et al. Concise Synthesis of Tunicamycin V and Discovery of a Cytostatic DPAGT1 Inhibitor. Angew Chem Int Ed. 2022;61:e202203225.
doi: 10.1002/anie.202203225
Hakulinen JK, Hering J, Brändén G, Chen H, Snijder A, Ek M, et al. MraY-antibiotic complex reveals details of tunicamycin mode of action. Nat Chem Biol. 2017;13:265–7.
pubmed: 28068312
doi: 10.1038/nchembio.2270
Yoo J, Mashalidis EH, Kuk ACY, Yamamoto K, Kaeser B, Ichikawa S, et al. GlcNAc-1-P-transferase–tunicamycin complex structure reveals basis for inhibition of N-glycosylation. Nat Struct Mol Biol. 2018;25:217–24.
pubmed: 29459785
pmcid: 5840018
doi: 10.1038/s41594-018-0031-y
Mashalidis EH, Lee SY. Structures of bacterial MraY and human GPT provide insights into rational antibiotic design. J Mol Biol. 2020;432:4946–63.
pubmed: 32199982
pmcid: 8351759
doi: 10.1016/j.jmb.2020.03.017
Hering J, Dunevall E, Snijder A, Eriksson PO, Jackson MA, Hartman TM, et al. Exploring the Active Site of the Antibacterial Target MraY by Modified Tunicamycins. ACS Chem Biol. 2020;15:2885–95.
pubmed: 33164499
doi: 10.1021/acschembio.0c00423
Takaki K, Davis JM, Winglee K, Ramakrishnan L. Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish. Nat Protoc. 2013;8:1114–24.
pubmed: 23680983
pmcid: 3919459
doi: 10.1038/nprot.2013.068
Tobin DM, Ramakrishnan L. Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis. Cell Microbiol. 2008;10:1027–39.
pubmed: 18298637
doi: 10.1111/j.1462-5822.2008.01133.x
Sridevi JP, Anantaraju HS, Kulkarni P, Yogeeswari P, Sriram D. Optimization and validation of Mycobacterium marinum-induced adult zebrafish model for evaluation of oral anti-tuberculosis drugs. Int J Mycobacteriol. 2014;3:259–67.
pubmed: 26786625
doi: 10.1016/j.ijmyco.2014.10.001
Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P, Ramakrishnan L. Real-Time Visualization of Mycobacterium-Macrophage Interactions Leading to Initiation of Granuloma Formation in Zebrafish Embryos. Immunity. 2002;17:693–702.
pubmed: 12479816
doi: 10.1016/S1074-7613(02)00475-2
Clark EM, Nonarath HJT, Bostrom JR, Link BA. Establishment and validation of an endoplasmic reticulum stress reporter to monitor zebrafish ATF6 activity in development and disease. Dis Model Mech. 2020;13:dmm041426.
pubmed: 31852729
pmcid: 6994954
Ellett F, Pase L, Hayman JW, Andrianopoulos A, Lieschke GJ. mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish. Blood. 2011;117:e49.
pubmed: 21084707
pmcid: 3056479
doi: 10.1182/blood-2010-10-314120
Matty MA, Knudsen DR, Walton EM, Beerman RW, Cronan MR, Pyle CJ, et al. Potentiation of P2RX7 as a host-directed strategy for control of mycobacterial infection. Garrett WS, Kana BD, Barczak A, editors. eLife. 2019;8:e39123.
Price NP, Labeda DP, Naumann TA, Vermillion KE, Bowman MJ, Berhow MA, et al. Quinovosamycins: new tunicamycin-type antibiotics in which the α, β-1″,11′-linked N-acetylglucosamine residue is replaced by N-acetylquinovosamine. J Antibiot (Tokyo). 2016;69:637–46.
pubmed: 27189123
doi: 10.1038/ja.2016.49
Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A Review of Antibiotic Use in Pregnancy. Pharmacotherapy. 2015;35:1052–62.
pubmed: 26598097
doi: 10.1002/phar.1649
Nakanishi K, Sudo T, Morishima N. Endoplasmic reticulum stress signaling transmitted by ATF6 mediates apoptosis during muscle development. J Cell Biol. 2005;169:555–60.
pubmed: 15897261
pmcid: 2171703
doi: 10.1083/jcb.200412024
Wang X, Karamariti E, Simpson R, Wang W, Xu Q. Dickkopf Homolog 3 Induces Stem Cell Differentiation into Smooth Muscle Lineage via ATF6 Signalling. J Biol Chem. 2015;290:19844–52.
pubmed: 26105053
pmcid: 4528144
doi: 10.1074/jbc.M115.641415
Habjan E, Ho VQT, Gallant J, van Stempvoort G, Jim KK, Kuijl C, et al. An anti-tuberculosis compound screen using a zebrafish infection model identifies an aspartyl-tRNA synthetase inhibitor. Dis Model Mech. 2021;14:dmm049145.
pubmed: 34643222
pmcid: 8713996
doi: 10.1242/dmm.049145
Dalton JP, Uy B, Okuda KS, Hall CJ, Denny WA, Crosier PS, et al. Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model. J Antimicrob Chemother. 2017;72:421–7.
pubmed: 27798206
doi: 10.1093/jac/dkw421
Demain AL. Antibiotics: Natural products essential to human health. Med Res Rev. 2009;29:821–42.
pubmed: 19291695
doi: 10.1002/med.20154
Cinaroglu A, Gao C, Imrie D, Sadler KC. Atf6 plays protective and pathologic roles in fatty liver disease due to endoplasmic reticulum stress. Hepatol Balt Md. 2011;54:495–508.
doi: 10.1002/hep.24396
Li J, Chen Z, Gao LY, Colorni A, Ucko M, Fang S, et al. A transgenic zebrafish model for monitoring xbp1 splicing and endoplasmic reticulum stress in vivo. Mech Dev. 2015;137:33–44.
pubmed: 25892297
doi: 10.1016/j.mod.2015.04.001
Yeh KY, Lai CY, Lin CY, Hsu CC, Lo CP, Her GM. ATF4 overexpression induces early onset of hyperlipidaemia and hepatic steatosis and enhances adipogenesis in zebrafish. Sci Rep. 2017;7:16362.
pubmed: 29180630
pmcid: 5703967
doi: 10.1038/s41598-017-16587-9
Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet Lond Engl. 2008;372:1319–27.
doi: 10.1016/S0140-6736(08)61203-9
Qiu W, Fang M, Magnuson JT, Greer JB, Chen Q, Zheng Y, et al. Maternal exposure to environmental antibiotic mixture during gravid period predicts gastrointestinal effects in zebrafish offspring. J Hazard Mater. 2020;399:123009.
pubmed: 32526431
doi: 10.1016/j.jhazmat.2020.123009
Bengmark S, Göransson G, Zoucas E. Defects in hemostasis produced by antibiotics. An in vivo study in the rat. Eur Surg Res Eur Chir Forsch Rech Chir Eur. 1981;13:290–8.
Ailes EC, Gilboa SM, Gill SK, Broussard CS, Crider KS, Berry RJ, et al. Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011. Birth Defects Res A Clin Mol Teratol. 2016;106:940–9.
pubmed: 27891788
pmcid: 5225492
doi: 10.1002/bdra.23570
Hoyberghs J, Bars C, Ayuso M, Van Ginneken C, Foubert K, Van Cruchten S. DMSO Concentrations up to 1% are Safe to be Used in the Zebrafish Embryo Developmental Toxicity Assay. Front Toxicol. 2021;3:804033.
pubmed: 35295145
pmcid: 8915880
doi: 10.3389/ftox.2021.804033
Maes J, Verlooy L, Buenafe OE, Witte PAM, de, Esguerra CV, Crawford AD. Evaluation of 14 Organic Solvents and Carriers for Screening Applications in Zebrafish Embryos and Larvae. PLOS ONE. 2012;7:e43850.
pubmed: 23082109
pmcid: 3474771
doi: 10.1371/journal.pone.0043850
Thuning CA, Fanshaw MS, Warren J. Mechanisms of the synergistic effect of oral dimethyl sulfoxide on antineoplastic therapy. Ann N. Y Acad Sci. 1983;411:150–60.
pubmed: 6576691
doi: 10.1111/j.1749-6632.1983.tb47297.x
Christou M, Kavaliauskis A, Ropstad E, Fraser TWK. DMSO effects larval zebrafish (Danio rerio) behavior, with additive and interaction effects when combined with positive controls. Sci Total Environ. 2020;709:134490.
pubmed: 31905542
doi: 10.1016/j.scitotenv.2019.134490
Kim K, Lee SE. Combined toxicity of dimethyl sulfoxide (DMSO) and vanadium towards zebrafish embryos (Danio rerio): Unexpected synergistic effect by DMSO. Chemosphere. 2021;270:129405.
pubmed: 33412354
doi: 10.1016/j.chemosphere.2020.129405
Uribe PM, Mueller MA, Gleichman JS, Kramer MD, Wang Q, Sibrian-Vazquez M, et al. Dimethyl Sulfoxide (DMSO) Exacerbates Cisplatin-induced Sensory Hair Cell Death in Zebrafish (Danio rerio). PLoS. 2013;8:e55359. https://dspace.mit.edu/handle/1721.1/78920
doi: 10.1371/journal.pone.0055359